Jessica Voss

Title: Jessica Voss: Innovator in Multispecific Binding Proteins

Introduction

Jessica Voss is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. Her innovative work has the potential to impact the treatment of autoimmune diseases.

Latest Patents

Jessica Voss holds a patent for CD28/OX40 bispecific antibodies. This patent describes multispecific binding proteins that include a first antigen binding domain (ABD) with binding specificity to CD28 and a second ABD with binding specificity to OX40. The patent also outlines methods for treating autoimmune diseases using these multispecific binding proteins.

Career Highlights

Jessica is currently employed at Sanofi, a global biopharmaceutical company. Her work at Sanofi focuses on advancing therapeutic solutions that address critical health challenges. With her expertise, she has contributed to the development of innovative treatments that can improve patient outcomes.

Collaborations

Jessica has collaborated with notable colleagues, including Gerald Beste and Yanik Bruynooghe. These partnerships have fostered a collaborative environment that enhances research and development efforts in her field.

Conclusion

Jessica Voss is a trailblazer in the field of biotechnology, with her patent on CD28/OX40 bispecific antibodies showcasing her innovative spirit. Her work at Sanofi and collaborations with esteemed colleagues further highlight her commitment to advancing medical science.